Novo Nordisk A/S (NVO)
38.16
-0.43
(-1.11%)
USD |
NYSE |
Feb 25, 16:00
38.08
-0.08
(-0.21%)
After-Hours: 20:00
Novo Nordisk Shareholders Equity (Annual) : 30.51B for Dec. 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Ascendis Pharma A/S | -191.23M |
| Evaxion AS | -1.652M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Viking Therapeutics, Inc. | 639.06M |
| DBV Technologies SA | 27.39M |